Francisco, Amanda FortesVieira, Paula Melo de AbreuArantes, Jerusa MarildaSilva, MaísaPedrosa, Maria LúciaSantos, Silvana Maria ElóiMartins Filho, Olindo AssisCarvalho, Andréa Teixeira deAraújo, Márcio Sobreira Silva2017-02-232017-02-232010FRANCISCO, A. F. et al. Increase of reactive oxygen species by desferrioxamine during experimental Chagas' disease. Redox Report, v. 15, p.185-190, 2010. Disponível em: <http://www.tandfonline.com/action/showCopyRight?scroll=top&doi=10.1179/174329210X12650506623528>. Acesso em: 10 jan. 2017.1351-0002http://www.repositorio.ufop.br/handle/123456789/7311Oxidative stress is common in inflammatory processes associated with many diseases including Chagas’ disease. The aim of the present study was to evaluate, in a murine model, biomarkers of oxidative stress together with components of the antioxidant system in order to provide an overview of the mechanism of action of the iron chelator desferrioxamine (DFO). The study population comprised 48 male Swiss mice, half of which were treated daily by intraperitoneal injection of DFO over a 35-day period, while half were administered sterile water in a similar manner. On the 14th day of the experiment, 12 DFO-treated mice and an equal number of untreated mice were experimentally infected with Trypanosoma cruzi. Serum concentrations of nitric oxide and superoxide dismutase and hepatic levels of total glutathione, thiobarbituric acid reactive species and protein carbonyl, were determined on days 0, 7, 14 and 21 post-infection. The results obtained revealed that DFO enhances antioxidant activity in the host but also increases oxidative stress, indicating that the mode of action of the drug involves a positive contribution to the host together with an effect that is not beneficial to the parasite.en-USrestritoOxidative stressTrypanosoma cruziArtigo publicado em periodicohttp://www.tandfonline.com/action/showCopyRight?scroll=top&doi=10.1179/174329210X12650506623528https://doi.org/10.1179/174329210X12650506623528